1. Home
  2. KTOS vs ROIV Comparison

KTOS vs ROIV Comparison

Compare KTOS & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kratos Defense & Security Solutions Inc.

KTOS

Kratos Defense & Security Solutions Inc.

N/A

Current Price

$84.81

Market Cap

13.4B

Sector

Industrials

ML Signal

N/A

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$21.05

Market Cap

15.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KTOS
ROIV
Founded
1994
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4B
15.8B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
KTOS
ROIV
Price
$84.81
$21.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
8
Target Price
$97.00
$24.31
AVG Volume (30 Days)
4.5M
5.6M
Earning Date
02-25-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
27.23
N/A
EPS
0.13
N/A
Revenue
$1,284,800,000.00
$13,310,000.00
Revenue This Year
$19.25
N/A
Revenue Next Year
$20.52
$741.42
P/E Ratio
$674.44
N/A
Revenue Growth
14.00
N/A
52 Week Low
$23.90
$8.73
52 Week High
$134.00
$23.91

Technical Indicators

Market Signals
Indicator
KTOS
ROIV
Relative Strength Index (RSI) 41.56 66.92
Support Level $84.50 $20.99
Resistance Level $103.49 $22.49
Average True Range (ATR) 8.33 0.67
MACD -4.52 0.00
Stochastic Oscillator 10.04 95.62

Price Performance

Historical Comparison
KTOS
ROIV

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: